Advances in Vaccine Formulation and Stability

David B. Volkin, PhD
Distinguished Professor, Pharmaceutical Chemistry, University of Kansas, Lawrence
Lessons Learned
from the Pandemic

Nicholas Warne, PhD,
Vice President, Pharmaceutical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc.
Emerging Platforms for New Modalities

Hari Pujar, PhD
Operating Partner, Flagship Pioneering, and Chief Operating Officer, Tessera Therapeutics
Cell and Gene Therapy (R)evolution

Mercedes Segura Gally, PhD
Vice President, Process Development, ElevateBio